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Abstract
The effects of PM10, one of the components of particulate air pollution, was investigated using
human monocytes and a mouse macrophage cell line (J774). The study aimed to investigate the role
of these nanoparticles on the release of the pro-inflammatory cytokine TNF-α and IL-1α gene
expression. We also investigated the role of intracellular calcium signalling events and oxidative
stress in control of these cytokines and the effect of the particles on the functioning of the cell
cytoskeleton. We showed that there was an increase in intracellular calcium concentration in J774
cells on treatment with PM10 particles which could be significantly reduced with concomitant
treatment with the calcium antagonists verapamil, the intracellular calcium chelator BAPTA-AM but
not with the antioxidant nacystelyn or the calmodulin inhibitor W-7. In human monocytes, PM10
stimulated an increase in intracellular calcium which was reduced by verapamil, BAPTA-AM and
nacystelyn. TNF-α release was increased with particle treatment in human monocytes and reduced
by only verapamil and BAPTA-AM. IL-1α gene expression was increased with particle treatment
and reduced by all of the inhibitors. There was increased F-actin staining in J774 cells after
treatment with PM10 particles, which was significantly reduced to control levels with all the
antagonists tested. The present study has shown that PM10 particles may exert their pro-
inflammatory effects by modulating intracellular calcium signalling in macrophages leading to
expression of pro-inflammatory cytokines. Impaired motility and phagocytic ability as shown by
changes in the F-actin cytoskeleton is likely to play a key role in particle clearance from the lung.
Introduction
Increased exposure to PM10 particles is associated with
adverse health effects [1,2]. Much of the mass of PM10 is
low in toxicity and it has been suggested that, combus-
tion-derived nanoparticles (ultrafine particles) [3-5] are a
key component that drives these effects, especially inflam-
mation. In individuals with pre-existing lung disease,
inhalation of nanoparticles may induce inflammation
and exacerbate respiratory and cardiovascular effects
through the induction of oxidative stress and inflamma-
tion [4,6,7]. Rat inhalation studies using nanoparticles of
various types, at high exposure, have demonstrated pul-
monary fibrosis, lung tumours, epithelial cell hyperplasia,
inflammation and increased cytokine expression [8-11].
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The alveolar macrophage plays an important role in parti-
cle-mediated inflammation by phagocytosing particles
and release of pro-inflammatory mediators such as the
cytokine tumor necrosis factor-alpha (TNF-α) [12]. The
signalling mechanisms for transcription of the TNFα gene
includes calcium-related pathways in diseases such as sep-
sis [13-15]. Calcium is released from the endoplasmic
reticulum stores on stimulation of the cell, leading to a
calcium influx across the plasma membrane via calcium
channels [16]. Various pathogenic particles have been
shown to produce such changes in calcium flux within the
cell [17,18] and a large number of pathological responses
could be stimulated via such calcium signalling.
In order for macrophages to migrate and phagocytose for-
eign material, an intact functional cytoskeleton is neces-
sary. The cytoskeleton is sensitive to ROS and oxidative
stress, due to the presence of thiol groups located on the
actin microfilaments. On oxidation, these filaments cross-
link, leading to reduced cell motility, impaired phagocy-
tosis and hence clearance of foreign material from the
lung. The cytoskeleton mediates several basic cell func-
tions: chemotaxis, migration, phagocytosis, phagosome-
lysosome fusion, and intracellular signalling [19-21]. Sev-
eral lines of evidence suggest that changes in actin fila-
ment organisation play an important role in macrophage
motility, adherence to surfaces and phagocytosis. Cellular
dysfunctions associated with the cytoskeleton can cause
retarded phagocytosis [22] and impaired phagosome-lys-
osome fusion [23], which may result in a diminished cel-
lular killing and clearance of particles and pathogens from
the lung.
The pro-inflammatory cytokine interleukin 1 (IL-1) is not
normally produced by the cells of healthy individuals,
exceptions being skin keratinocytes, some epithelial cells
and some cells of the central nervous system. In response
to inflammatory stimuli, however, there is a dramatic
increase in the production of IL-1 by macrophages and
other cell types [24]. There are two distinct proteins, IL-1α
and IL-1β which are the products of two distinct genes but
which recognise the same cell surface receptors [25]. IL-1
possesses a wide variety of biological activities. As well as
inducing its own synthesis, IL-1 stimulates the secretion of
TNF-α and IL-6 from macrophages/monocytes [26,27].
Normal production of IL-1 is vital for host responses to
injury and infection, while prolonged secretion has been
linked with a number of pathological conditions [28,29].
Our hypothesis in this study was that PM10 particles pro-
duce cytokine release and cytokine gene expression in
macrophages by a process which involves calcium signal-
ling and reactive oxygen species (ROS). Furthermore, we
hypothesise that other effects of PM10, such as alterations
in the cytoskeleton, are also mediated via signalling proc-
esses involving both ROS and calcium.
Materials and Methods
Particle Characteristics
Collection of PM10 samples was co-ordinated by Casella
Stanger, London, England. Particles were collected onto
TEOM filters in Marylebone Road, London, a site which
had particularly high levels of traffic and therefore high
levels of primary, combustion-derived nanoparticles.
Ultrafine carbon black (UfCB) was obtained from
Degussa (Printex 90), the average particle size was 14 nm.
The characteristics and details of UfCB particles have been
published previously [30].
Particle Quantification
A single PM10 filter was placed into a bijou bottle and 0.5
ml phosphate buffered saline (PBS) added. The bottle was
vortexed for 4 minutes to remove the particles from the fil-
ter and the resulting suspension transferred to a clean
bijou bottle. The mass of particles was assessed by densit-
ometry. As standards, a series of dilutions of UfCB parti-
cles were made, ranging from 15.625 µg/ml to 1 mg/ml in
saline, sonicated for 5 minutes, and 75 µl of each concen-
tration was added into triplicate groups of wells in a 96-
well plate. Seventy-five microlitres of PM10 sample were
added into a separate triplicate group of wells. The sam-
ples and standards were then read on a plate reader at 340
nm and the mass of particles calculated from a linear
regression of the UfCB standards.
J774.A1 Cell Culture
The mouse macrophage cell line J774.A1 (a kind gift from
Dr W Muller GSF, Gauting, Germany) was routinely cul-
tured in RPMI medium (Sigma) containing 5% foetal calf
serum (FCS) and Penicillin/Streptomycin. Cells were cul-
tured until confluency was reached and then scraped from
the surface of the flasks using a cell scraper. The cells were
counted and adjusted to 5 × 105/ml in RPMI plus 5% FCS.
Sterile 10 mm glass cover slips were placed in each well of
a 24-well plate and 1 ml of cell suspension added to each
well. Cells were incubated at 37°C for 24 hours prior to
particle treatment.
Isolation of Human Peripheral Blood Mononuclear Cells
Human peripheral blood mononuclear cells were pre-
pared according to the protocol of Dransfield et al, [31].
In brief, two separate volumes of 40 ml of blood were
withdrawn from healthy consenting volunteers and trans-
ferred to 50 ml sterile Falcon tubes containing 4 ml of
3.8% sodium citrate solution. Tubes were gently inverted
and centrifuged at 250 g for 20 minutes, the plasma
removed from each tube and pooled without disturbing
the cell pellet. Dextran (Pharmacia), prepared as a 6%
solution in saline was warmed to 37°C, before adding to
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the cell pellet (2.5 ml/10 ml cell pellet) and the volume
made up to 50 ml with sterile saline. Tubes were gently
mixed and the cells allowed to sediment at room temper-
ature for 30 minutes. In order to prepare autologous
serum, calcium chloride solution (220 µl 1 M/10 ml), was
gently mixed with the plasma and incubated in a glass
tube at 37°C until the clot retracted. Percoll (Pharmacia)
gradients were made from a stock solution of 90% (18 ml
Percoll + 2 ml 10x PBS, (Life Technologies, Paisley) with-
out calcium or magnesium) to give final concentrations of
81%, 70% and 55% using 1x PBS. The separating gradient
was prepared by layering 2.5 ml of 70% percoll over 2.5
ml 81% percoll. The leukocyte-rich fraction from the dex-
tran sedimentation was transferred to sterile falcon tubes,
0.9% saline added to give a final volume of 50 ml and the
tubes centrifuged at 250 g for 6 minutes. The pellet was
resuspended in 55% percoll and 2.5 ml layered over the
previously prepared separating gradients. Tubes were cen-
trifuged at 290 g for 20 minutes and the mononuclear
cells collected from the 55/70 layer. Cells were washed
twice with PBS, counted, and resuspended in RPMI
medium at a concentration of 5 × 106 cells/ml and 1 ml
added to each well of a 24 well plate. For calcium imaging,
cells were also set up in 6-well plates containing a 26 mm
diameter sterile glass coverslip. The cells were incubated
for 1 hour at 37°C, the medium removed and replaced
with RPMI plus 10% autologous serum and incubated for
48 hours at 37°C. After the second incubation, the
medium was replaced and the cells incubated for a further
72 hours prior to treatment.
Cell Treatments
PM10 particles were diluted to give a final concentrations
ranging from 5 µg/ml to 40 µg/ml in RPMI medium with-
out serum and the suspension was sonicated for 5 min-
utes to disperse the particles. Cells which had been set up
as described above, were washed twice with sterile PBS
and 250 µl of particle suspension added to appropriate
wells. UfCB particles were quantified as described for the
PM10 and set up in parallel with PM10 particles at similar
mass concentrations with J774 cells to investigate TNF-α
release. One well received medium only (-ve control) and
one received 250 µl of 1 µg/ml LPS (+ve control). The cal-
cium antagonists were added concomitantly with the par-
ticles to give final concentrations of verapamil (100 µM),
BAPTA-AM (50 µM), W-7 (250 µM), trolox (25 µM), and
nacystelyn (5 mM). The cells were then incubated at 37°C
for 4 hours and the supernatants removed and stored at -
80°C until required. The cells cultured on 10 mm cover
slips were fixed by the addition of 3% formaldehyde.
J774.A1 Intracellular Calcium Measurements
J774.A1 cells were cultured and removed from flasks as
described above. Cells were pooled into a single tube,
adjusted to 4.5 × 106 cells/ml in RPMI plus 10% FCS and
incubated at 37°C until required for the assay. One milli-
litre of cell suspension was transferred to an Eppendorf
tube, centrifuged at 145 g for 2 minutes, the medium
removed, the cell pellet resuspended in 1 ml PBS and
again centrifuged at 145 g for 2 minutes. The PBS was
removed and cells resuspended in serum-free RPMI
medium containing 23 mM Hepes buffer. Cells were
loaded with 1 µg/µl Fura 2-AM (Sigma) in DMSO, 2 µl/ml
cell suspension, the tube wrapped in foil and incubated in
a shaking water bath for 20 minutes at 34°C. After incu-
bation, the tube was centrifuged at 145 g for 2 minutes at
4°C, the medium removed and replaced with 1.5 ml fresh
RPMI without serum. The Fura 2-AM-loaded cells were
transferred to a quartz cuvette with stirrer and placed
immediately into a fluorimeter with heated block and
basal fluorescence measurements obtained over a 100 sec-
ond period. The fluorimeter was set up with to give excita-
tion wavelengths of 340 nm and 380 nm, emission 510
nm and excitation and emission slit widths set at 5 nm.
During the experiments, the cuvette temperature was kept
constant at 37°C. After 100 seconds, 10 µl appropriate
treatment in RPMI medium was added to the cuvette and
the experiment allowed to run for a further 1700 seconds.
Treatments consisted of PM10 to give a final concentration
of 10 µg/ml with and without the calcium antagonists at
the concentrations described above. Twenty microlitres of
5% Triton solution were added to the cuvette to lyse the
cells to give the maximum fluorescence (Rmax) and the
experiment continued for 500 seconds. To give the mini-
mum fluorescence value (Rmin), 15 µl of 0.5 M EGTA in
3 M Tris buffer were added to the cuvette. The experiment
was terminated after a further 500 seconds. The ratio of
the fluorescence measurements at excitation wavelengths
of 340 and 380 nm were converted to calcium concentra-
tion values using the method of Grynkiewicz et al, [32].
Human and mouse TNF-α ELISA
The supernatants previously prepared were assayed for
TNF-α protein content using a commercially available
human TNF-α kit (Biosource) or mouse TNF-α kit (R&D
Systems) according to the manufacturer's instructions.
Briefly, each well of a 96-well plate was coated overnight
with capture antibody, before washing with PBS contain-
ing 0.05% tween, and then adding test supernatant to the
appropriate wells in triplicate groups. After incubation for
2 hours at room temperature, the wells were washed, a
detection antibody added and incubated for a further
hour at room temperature. The wells were then washed
with PBS/tween before addition of Horseradish peroxi-
dase (HRP)-conjugated streptavidin and incubated for 45
minutes at room temperature. Finally, the colour was
developed by adding peroxidase substrate to each well,
before reading the absorbance at 450 nm using a Dynatec
plate reader.
Respiratory Research 2004, 5:29 http://respiratory-research.com/content/5/1/29
Page 4 of 12
(page number not for citation purposes)
mRNA Extraction
The experiments described above were also used to gener-
ate cells for total RNA extraction. After removal of the
supernatant, 400 µl Tri reagent (Sigma) was added to each
well. The lysed cells were then scraped from the surface of
the plate using a cell scraper and transferred to Eppendorf
tubes. Two hundred microlitres of chloroform were added
to each Eppendorf, vortexed for 15 seconds and allowed
to stand at room temperature for 15 minutes. The result-
ing mixture was centrifuged at 12000 g for 15 minutes at
4°C. The colourless upper phase was transferred to a fresh
Eppendorf, before adding 450 µl isopropanol. The mixed
samples were allowed to stand for a further 10 minutes at
room temperature. Again the tubes were centrifuged at
12000 g for 10 minutes at 4°C, the supernatant removed
and the RNA pellet washed in 1 ml of 75% ethanol. The
resulting samples were then vortexed briefly, centrifuged
at 7500 g for 5 minutes at 4°C and the RNA pellet air-
dried for 10 minutes. The RNA was then suspended in 50
µl diethylpyrocarbonate (DEPC)-treated water and stored
at -70°C until required for quantification and Reverse
Transcriptase-Polymerase Chain Reaction (RT-PCR).
RT-PCR
The RT-PCR procedure was carried out using the Promega
Access Kit. Briefly, a master mix of the kit reagents was pre-
pared according to the manufacturers instructions. Ten
microlitres of RNA at 0.03 µg/ml was added to 40 µl of the
master mix, containing 10 µl of the appropriate human
primers Glyceraldehyde Phosphate Dehydrogenase
(GAPDH) or IL-1-α (MWG AG Biotech, Ebersberg, Ger-
many). Tubes were placed in a thermal cycler which was
programmed for the following temperatures and times.
Following an initial 45 minute incubation at 48°, samples
were cycled as follows: 94°C for 2 minutes, 95°C for 30
seconds, 60°C for 1 minute, 68°C for 2 minutes. This
cycle was repeated 25 times for GAPDH and 30 times for
IL-1 alpha. To conclude, the sample was incubated at
68°C for 7 minutes and then cooled to 4°C. The resulting
RT-PCR products were separated by electrophoresis using
a 2% agarose gel containing 1 µg/ml ethidium bromide
and viewed under UV light. The RT-PCR bands were quan-
tified by densitometry using Syngene software and the IL-
1α band intensity was expressed as a percentage of the cor-
responding GAPDH band. These results were then
expressed as a percentage of the untreated control.
Calcium Imaging
Human mononuclear cells were isolated from blood as
previously described followed by adhesion onto 26 mm
glass coverslips contained in 6-well plates. Cells were
seeded in RPMI medium containing 0.1% BSA and peni-
cillin/streptomycin at a density of 5 × 105 cells/ ml and
incubated at 37°C, 5% CO2 for 1 hour before washing
with 1 ml PBS. Prior to particle treatment and digital
enhanced video microscopy (Roper scientific), cells were
loaded with the calcium-sensitive dye, Fura 2-AM (2 µg/
ml in RPMI) (Sigma) for 30 minutes at 37°C. The cover-
slips were then washed with PBS, assembled into the
microscope holder and 400 µl RPMI medium without
phenol red (Sigma) added. The fluorescence ratio was
observed (excitation 340 and 380 nm, emission 510 nm)
at a magnification of 63× (Zeiss Axiovert microscope).
Images were captured every 2 seconds by a Coolsnap fx
Photometrics (Roper Scientific) camera controlled by
Metafluor software. After 100 seconds particle treatment
was added to the cells (100 µl of a 250 µg/ml stock solu-
tion of particles to give a final concentration of 50 µg/ml)
contained in phenol red-free RPMI medium.
F-Actin Staining
The cells cultured on cover slips and fixed with formalde-
hyde were washed three times with PBS and permeablised
with 0.1%Triton for 4 minutes. Cells were then washed
three times with PBS and the F-actin stained using 33 ng/
ml Phalloidin-FITC (Sigma) in PBS for 30 minutes at
room temperature. Cells were washed three times with
PBS before staining with propidium iodide (10 µg/ml in
PBS) for 5 seconds. Cells were further washed three times
with PBS before being mounted on glass slides using Cit-
ifluor mounting medium. The cells were then examined
using an Axiofluor fluorescence microscope. Images were
captured and quantified using Metamorph software (Uni-
versal Imaging Corporation). Seven fields of view were
captured from each treatment and the images decon-
volved using the image software. The staining intensity of
each cell was then measured using the analysis software.
Statistical Analysis
Data from all of the experiments were analysed using
analysis of variance with Tukey or Fishers multiple com-
parison test. Significance was set at p < 0.05.
Results
Intracellular Calcium Concentration in PM10-Treated 
J774.A1 Cells
The effects of PM10 on J774 murine macrophages was
investigated at final concentrations of 5, 10 or 25 µg/ml
PM10. Treatment of the cells with these particles produced
a dose-dependent increase in cytosolic calcium concentra-
tion [Ca2+]c up to a concentration of 10 µg/ml. At 25 µg/
ml the [Ca2+]c decreased to a value similar to the 5 µg/ml
particle concentration. (Figure 1a). Subsequent treatment
with thapsigargin to release the endoplasmic reticulum
calcium store produced a further increase in cytosolic Ca2+
indicating that the cells remained viable and confirming
previous studies [33]. There was a statistically significant
difference between control and PM10 treatments at 10 µg/
ml (p < 0.05). The [Ca2+]c following concomitant treat-
ment of cells with particles and calcium antagonists was
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The cytosolic calcium concentration (nM) in J774 cells on treatment with 5–25 µg/ml PM10 particles for 1700 seconds (a) and with 10 µg/ml PM10 particles plus calcium a tagonists (b)Figure 1
The cytosolic calcium concentration (nM) in J774 cells on treatment with 5–25 µg/ml PM10 particles for 1700 seconds (a) and 
with 10 µg/ml PM10 particles plus calcium antagonists (b). There was a significant difference only at the 10 µg/ml particle dose 
from the control (p < 0.05). With calcium antagonist treatment, there was a significant difference between all of the treatments 
and the control (p < 0.05). Data represents the mean ± SEM of the intracellular calcium concentration (nM). (n = 3).
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reduced (figure 1b). Both the calcium channel blocker
verapamil, and the calcium chelator BAPTA-AM signifi-
cantly reduced (p,0.05) the intracellular calcium com-
pared with PM10 alone. In contrast, the antioxidant
Nacystelyn did not significantly reduce the PM10-stimu-
lated [Ca2+] increase, with Ca2+ concentration remaining
significantly greater than the control value (p < 0.05). In
our previous studies [34,35] we demonstrated that the
antagonists used at the same concentrations used here
caused no toxic effects to cells and that the drug treatment
produced similar results to the untreated controls.
Intracellular Calcium Concentration in PM10-Treated 
Human Monocytes
PM10 also induced a significant increase in cytosolic cal-
cium in the primary human monocytes (p < 0.05). The
dose of 10 µg/ml final concentration was chosen as the
dose at which a significant increase in [Ca2+]c had previ-
ously been observed (figure 1a). At time points from 600
to 800 seconds after the addition of particle/antagonist
treatment, there was a rapid increase in [Ca2+]c with parti-
cles alone compared with the antagonists. In contrast to
the antagonist treatment effects reported in figure 1, the
antioxidant nacystelyn significantly inhibited the [Ca2+]c
changes induced in the human monocytes treated with 10
µg/ml PM10 (figure 2). Both the intracellular calcium che-
lator BAPTA-AM and the calcium channel blocker vera-
pamil also significantly inhibited the [Ca2+]c rise
compared with particles alone (p < 0.05).
Effect of UfCB and PM10 particles on TNF-α release by 
J774 cells
A comparison of the gram for gram dose effect of PM10
and UfCB particles on TNF-α release by J774 macrophages
is shown in figure 3. The data show that PM10 particles
caused significantly more TNF-α release as the same mass
of UfCB particles by the mouse macrophage cell line.
TNF-α release in PM10-treated Human Monocytes
The release of TNF-α protein by human monocytes after
treatment with varying concentrations of PM10 is shown
in figure 4. The dose of particles ranged from 5 µg/ml to
The intracellular calcium concentration (nM) in human monocytes on treatment with PM10 at a concentration of 10 µg/mlFigure 2
The intracellular calcium concentration (nM) in human monocytes on treatment with PM10 at a concentration of 10 µg/ml. Par-
ticles and calcium antagonists were added at zero time and the experiment run for 800 seconds in total (first 800 seconds 
shown). There was a significant difference between PM10-treated cells and PM10 and calcium antagonist treatment at each time 
point tested (p < 0.05). Data represents the mean ± SEM of the ratio of 340/380 nm. (n = 3).
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40 µg/ml with concomitant treatment with calcium antag-
onists. There was a clear dose response of particle treat-
ment from 10 µg/ml to 40 µg/ml. Within this range, the
TNF-α concentration was approximately 170 pg/ml to
1000 pg/ml. At higher particle doses, the calcium antago-
nists reduced TNF-α release only marginally with the most
dramatic and significant effect being seen with a particle
concentration of 10 µg/ml with verapamil (V) and
BAPTA-AM (B) treatments which reduced TNF-α release
to 29 pg/ml and 7 pg/ml respectively (p < 0.05). There was
no reduction in PM10 induced TNF-α release with W-7
(W), Trolox (T) or Nacystelyn (N) at any particle dose
tested.
IL-1 mRNA Expression
Treatment of human peripheral blood monocytes with 10
µg/ml PM10 for 4 hours produced a significant increase in
IL-1α mRNA content compared with unstimulated cells
(p < 0.05) (figure 5). The IL-1α band intensities were
expressed as a percentage of the GAPDH band intensities
and then normalised to the unstimulated control. PM10
induced a five fold increase in IL-1α mRNA expression
compared with the control and on treatment with the cal-
cium antagonists, this was reduced to values similar to the
control. There was a significant difference between the
PM10 exposed cells and concomitant treatment with all of
the calcium antagonists and antioxidants tested (p <
0.05).
F-Actin Staining
The fluorescence intensity of cells stained for F-actin after
treatment with PM10 particles and calcium antagonists is
shown in figure 6. Particles alone significantly increased
the phalloidin-FITC fluorescence and hence the F-actin
content of the cells compared with untreated cells. All of
the calcium antagonists tested inhibited the PM10 induced
increase in F-actin intensity to control levels and this was
significantly different from particle only treatment (p <
0.05), although the increase in the fluorescence intensity
of the PM10-treated cells was modest (a 5% difference).
TNF-α protein release in J774 cells treated with UfCB or PM10 for 4 hoursFigure 3
TNF-α protein release in J774 cells treated with UfCB or PM10 for 4 hours. There was significantly more TNF-α release in 
PM10 treated cells compared with an equal mass of UfCB. Data represents the mean ± SEM pg/ml TNF-α release (n = 3).
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TNF-α release by human monocytes after treatment with PM10 (5–40 µg/ml) and with concomitant treatment with calcium antagonists for 4 ho rs verapamil (V), BAPTA-AM (B), W-7 (W), trolox (T), a  nacystelyn (N)Figure 4
TNF-α release by human monocytes after treatment with PM10 (5–40 µg/ml) and with concomitant treatment with calcium 
antagonists for 4 hours verapamil (V), BAPTA-AM (B), W-7 (W), trolox (T), and nacystelyn (N). There was a significant differ-
ence between the untreated control and PM10 treatment only for the 10 µg/ml dose (p < 0.05). Data represents the mean ± 
SEM pg/ml TNF-α release (n = 5).
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IL-1α mRNA expression in human monocytes treated with 10 µg/ml PM10 particles with and without calcium antagonists for 4 hoursFigure 5
IL-1α mRNA expression in human monocytes treated with 10 µg/ml PM10 particles with and without calcium antagonists for 4 
hours. The top panel shows a typical gel. The graph shows the IL-1α expression as a percentage of the GAPDH and normalised 
to the control. There was significantly greater expression of IL-1α mRNA in the PM10 treatment which was reduced to control 
levels with calcium antagonist treatment. Data represents the mean ± SEM of the mRNA intensity. (n = 3).
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Discussion
There is evidence that increases in particulate air pollution
correlate with increased morbidity and mortality from res-
piratory and cardiovascular causes [1,36-38] and the pro-
inflammatory effects of PM10 are considered to drive these
effects [39,40]. The present study aimed to investigate the
effect of PM10 particles on oxidative stress- and calcium-
related cytokine regulation in human monocytes and on
the cytoskeleton in mouse J774 cells.
We have previously shown that ultrafine or nanoparticles
enhanced the calcium influx into cells of a monocytic cell
line (MM6) [19,34] and that these [Ca2+]c changes lead to
production of the proinflammatory cytokine TNF-α [35].
We demonstrate here using calcium imaging, that PM10
particles can also stimulate entry of extracellular calcium
into both J774 macrophages and human macrophage
derived monocytes, and that this process is inhibited by a
calcium channel blocker suggesting that the PM10, in a
similar fashion to UfCB induces opening of plasma mem-
brane calcium channels leading to a calcium influx. The
results obtained using the antioxidant nacystelyn were
confusing. In the J774 macrophages nacystelyn was
unable to inhibit PM10 induced increases in cytosolic cal-
cium concentration, whereas the same antioxidant was
very effective in the human monocyte derived
macrophages. This difference could be due to a species dif-
ference or a comparison between a cell line and primary
cells. A number of cell lines have been demonstrated to
exhibit aberrant calcium signalling pathways. Our previ-
ous studies using human macrophages suggest that
ultrafine particle-induced increases in cytosolic calcium
can be mediated by ROS [35] and since a large proportion
of the particles within PM10 are ultrafine, it is conceivable
that much of the calcium increase is ROS mediated, at
least in part. However, PM10 also contains other sub-
stances, such as metals, that could influence this pathway.
Metals would in fact be expected to increase the ROS pro-
duction by the PM10 particles [41].
The fluorescence intensity of F-actin stained J774 cells after 10 µg/ml PM10 treatment and with calcium antagonist treatment for 4 hoursFigure 6
The fluorescence intensity of F-actin stained J774 cells after 10 µg/ml PM10 treatment and with calcium antagonist treatment for 
4 hours. There was a significant difference in the intensity of PM10-treated cells compared with the untreated control (p < 
0.05). There was no significant difference between the control and any other treatment. Data represents the mean ± SEM of 
the fluorescence intensity of the cells. (n = 3).
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The present study clearly shows that the same dose of
PM10 (10 µg/ml) that induces calcium elevation also stim-
ulates significant increases in both TNF-α protein release
and IL-1α mRNA production by macrophages. The cal-
cium channel blocker verapamil and the intracellular
calcium chelator BAPTA-AM reduced the calcium
increase, TNF-α protein release and IL-1 mRNA
expression by human monocytes when stimulated with
PM10 particles. This is strong evidence to suggest that
influx of extracellular calcium plays a key role in upregu-
lating the proinflammatory response induced by PM10
that could lead to disease. However, the calmodulin
inhibitor W-7 had little effect on TNF-α release, while it
did inhibit IL-1 mRNA expression. The antioxidants also
had variable abilities to block cytokine expression, inhib-
iting IL-1 mRNA production but not TNF-α protein
release. These differences could be explained either by
divergent pathways controlling expression of the two
cytokines, or that TNF-α protein was measured in compar-
ison to IL-1 mRNA. However, clearly both calcium and
ROS are important in the regulation of IL-1α mRNA
expression while only calcium is important in controlling
TNF-α expression in macrophages exposed to PM10.
These studies indicate that on an equal mass basis PM10 is
far more potent that UfCB in terms of its ability to induce
TNF-α protein release. This is likely to be due to other
components, such as metals and organic compounds
other than the carbon core, within PM10 that can promote
inflammation. It is also possible that components such as
the UF particles and metals could interact to enhance tox-
icity as has been shown for ROS production in vitro and
inflammation in vivro [41]. Our previous studies have
failed to detect LPS in the PM10 particles, therefore it is
unlikely that cytokine release, changes in intracellular cal-
cium, and IL-1α gene expression can be explained solely
by endotoxin.
As explained previously, the cytoskeleton is the scaffold of
cells, and in the case of motile cells such as macrophages
it is responsible for controlling movement. Disruption of
the cytoskeleton, particularly via oxidative stress, is
thought to disrupt cellular structure and hence function
[42]. We have previously demonstrated that PM10 gener-
ates ROS [43]. The ability of the antioxidants trolox and
nacystelyn to prevent the PM10 induced increase in F-actin
staining in this study demonstrates that particle-derived
ROS impact on the macrophage cytoskeleton. Our previ-
ous studies also demonstrate that Uf particle-induced
ROS play a role in elevating the cytosolic calcium concen-
tration of macrophages leading to increased TNF-α pro-
duction [35]. The results of this study also suggest that
both calcium signalling and ROS are important in modu-
lating the F-actin cytoskeleton in response to PM10 expo-
sure. As has been shown by other workers [44,45], in both
the macrophage cell line and primary cells that F-actin is
distributed as microfilaments around the cell, with special
prominence at the leading edge of the cells. The microtu-
bules in contrast are situated throughout the cell. Micro-
tubules and actin filaments have previously been studied
as targets of antitumour drugs [46] which mainly work by
acting on microtubules and alter the dynamics of actin
filaments. Changes in the distribution of actin filaments
and their expression compared with normal cells may
indicate alterations in the phagocytic ability of macro-
phages which may eventually lead to impaired particle
clearance from the lungs. We show here that treatment of
macrophages with PM10 particles increased the F-actin flu-
orescence signal in cells stained with FITC-labelled phal-
loidin, although changes in the distribution of actin
filaments was not apparent from microscope analysis
there appeared to be more cortical staining. In accord with
the role of calcium and ROS in the induction of IL-1
expression, both of these factors appeared to play an
important role in modulating the F-actin cytoskeleton.
The present study has shown that PM10 particles may exert
their increased pro-inflammatory effects by modulating
intracellular calcium signalling in macrophages leading to
expression of proinflammatory cytokines. An additional
consideration is the effects of particles on the cytoskeleton
of the cell. Impaired cellular motility and phagocytic abil-
ity is likely to play a key role in particle clearance from the
lung, thus perpetuating the effects of PM10. The role of
calcium and ROS in other cellular responses are under
investigation.
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